A promising treatment for terminal cancer patients may be just the beginning
December 15, 2023 - Researchers in Ottawa and Vancouver are building a made-in-Canada network to treat patients with acute lymphoblastic leukemia and other cancers |
Meet Dr. Natasha Kekre, The Ottawa Hospital’s new Research Chair in Advanced Stem Cell Therapy
September 18, 2023 - The best part of Dr. Natasha Kekre’s workday is when she is able to offer hope to her patients through clinical trials. As The Ottawa Hospital’s new Research Chair in Advanced Stem Cell Therapy, Dr. Kekre is looking forward to many more hopeful ... |
Bringing cellular immunotherapy to solid tumours: made-in-Canada approach to be pioneered in biliary tract cancers thanks to $7.4M grant
April 13, 2023 - Canadians with biliary tract cancer (cholangiocarcinoma and gallbladder) will have the first chance to benefit from a new made-in-Canada approach to personalized cellular immunotherapy, thanks to a $7.4 million grant from the Canadian Cancer ... |
Dr. Natasha Kekre wins national recognition for early career success
March 15, 2023 - Dr. Kekre's early-career work has secured millions in funding and led to numerous peer-reviewed publications as she’s helped advance the immunotherapy field in Canada. |
Meet Dr. Natasha Kekre
January 26, 2023 - A hematologist for our Transplant and Cellular Therapy Program, Dr. Kekre is also an associate scientist in our Clinical Epidemiology Program and an associate professor at the University of Ottawa. |
Made-in-Canada approach enhancing access to groundbreaking CAR-T cancer therapy
January 19, 2023 - Researchers at The Ottawa Hospital are partnering with colleagues across the country to expand access to new technology that turns patients’ immune cells into super-charged cancer-killers. |
CAR-T clinical trial provides ‘one last shot’ for leukemia patient
January 11, 2023 - Camille Leahy was out of options. Here's what led her to a Canadian-first CAR T-cell therapy clinical trial at our hospital. |
Canadian-Led Immunotherapies in Cancer (CLIC) program inspires innovative CAR-T trial in Denmark
December 8, 2022 - CAR-T therapy is a groundbreaking cancer treatment that involves genetically engineering a patient’s own immune cells to attack their cancer. While this therapy is commercially available in many countries, cancer researchers are also developing ... |
First made-in-Canada CAR-T cell therapy for cancer shows promise in clinical trial
June 17, 2022 - More than a dozen people with cancer who had exhausted all treatment options are alive and cancer-free today thanks to a pioneering Canadian clinical trial of a highly personalized kind of immunotherapy. |
First made-in-Canada CAR-T therapy gives lymphoma patient a third chance
January 10, 2022 - Faced with the return of his lymphoma for the third time in ten years, Owen Snider was running out of options. But there was new hope when he was accepted into a made-in-Canada CAR-T therapy clinical trial. |
Medicine’s future: living drugs
November 19, 2021 - The Ottawa Hospital’s Biotherapeutics Manufacturing Centre harnessing the life-saving power of biological therapies |
Experts on call: Stem cells, gene therapy and biotherapeutics
April 22, 2021 - Could biotherapeutics be the key to the next wave of medical breakthroughs? Join this lively discussion to learn how researchers at The Ottawa Hospital are using biological materials like cells, genes and viruses to heal the body and fight disease. |
Cancer team awarded $5M for cell-based immunotherapy research
March 3, 2021 - Researchers at The Ottawa Hospital and the University of Ottawa are partnering with colleagues across the country to expand Canada’s capacity to develop new cell-based immunotherapies for cancer with a $5.2 million grant from the Canada ... |
One small step for blood cancer patients, one giant step for Canadian cancer patients of all stripes
February 25, 2021 - The Canadian-Led Immunotherapies in Cancer (CLIC) research program is building Canada’s capacity for innovation in CAR-T therapy, with support from BioCanRx, The Ottawa Hospital, BC Cancer and the Ontario Institute for Cancer Research |
The Ottawa Hospital and uOttawa launch new cancer immunotherapy research projects with funding from BioCanRx
September 22, 2020 - BioCanRx, Canada’s Immunotherapy Network, today announced funding of $10M for 14 cancer immunotherapy research projects and eight core and biomanufacturing facilities across the country. Researchers at The Ottawa Hospital (TOH) and the University ... |
Could biotherapeutics be the next revolution in cancer treatment?
February 20, 2020 - From helping the body’s own immune system better detect and fight cancer, to treating cancer with immune cells, viruses and vaccines, The Ottawa Hospital is conducting cutting-edge research that could transform cancer care right here at home and ... |
Ottawa a “hotbed of patient partnerships in research”
September 27, 2019 - The Ontario SPOR Support Unit’s summer newsletter showcases how Ottawa has become a “hotbed of patient partnerships in research.” Three stories demonstrate how researchers at The Ottawa Hospital are partnering with patients and caregivers to ... |
The promise of CAR-T therapy for cancer: meta-analysis shows the big picture
August 14, 2019 - CAR-T therapy, which uses a patient’s own genetically modified immune cells, is one of the most exciting advances in cancer treatment. To get a big picture view of the field, Drs. Manoj Lalu and Dean Fergusson led a team that analyzed data from ... |
Patients and clinical trial experts key to upcoming made-in-Canada CAR-T clinical trial
March 1, 2019 - Researchers at The Ottawa Hospital and the University of Ottawa are known around the world for their expertise in designing and leading clinical trials, and they're now applying this knowledge to create a made-in-Canada approach for CAR-T ... |
Ottawa researchers to play lead role in new cancer immunotherapy studies
February 15, 2017 - BioCanRx funds research into CAR-T and virus-infected cell therapy
Researchers from The Ottawa Hospital and the University of Ottawa will play a lead role in cutting-edge research on cancer immunotherapy, thanks to five new peer-reviewed researc |
